跳至主要内容
临床试验/NCT02514122
NCT02514122已完成2 期

Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda: a Randomized Control Trial

University of Saskatchewan1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
61
试验地点
1
主要终点
Postoperative Pain as Measured on a 11-point Numerical Rating Scale

研究概览

简要总结

A randomized double blind control trial to investigate the safety and efficacy of subcutaneous ketamine for control of post operative pain in low resource settings.

详细描述

A randomized double blind control trial. All patients undergoing upper abdominal, thoracic, gynecologic or orthopaedic surgeries at the Centre Hospitalier Universitaire de Kigali, Kigali, Rwanda will be invited to participate. Enrolled patients will receive subcutaneous ketamine (or placebo) administered immediately after surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections at a dose of 1mg/kg. The primary outcome will be a reduction in mean Pain Scores using parametric statistical analysis to discriminate significance. Pain will be measured using an 11-point numerical rating scale. Secondary outcomes will be the presence of significant side effects. This trial is a partnership between the University of Saskatchewan and the National University of Rwanda with ethics approval from each institutions ethics board.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • All patients undergoing upper abdominal, thoracic, gynecologic or orthopaedic surgeries during a one month period with expected post operative hospital admission

排除标准

  • Allergy to Ketamine
  • History of narcotic abuse or dependence
  • Those patients for which decreased cognitive function is a barrier to accurate data collection

研究组 & 干预措施

Ketamine

Experimental

Participants will receive subcutaneous ketamine (1mg/kg) administered immediately after surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections at a dose of 1mg/kg.

干预措施: Ketamine (Drug)

Saline

Placebo Comparator

Participants will receive subcutaneous saline (0.02cc/kg) administered immediately after surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections.

干预措施: Saline (Drug)

结局指标

主要结局

Postoperative Pain as Measured on a 11-point Numerical Rating Scale

时间窗: The average of twice daily pain scores, from end of surgery until 60 hours postoperative.

Pain will be measured using an 11-point numerical rating scale from 0 (no pain) to 10 (worst pain imaginable) units on a scale.

次要结局

  • Hallucination(From end of surgery until 60 hours postoperative.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

William McKay

MD FRCPC

University of Saskatchewan

研究点 (1)

Loading locations...

相似试验